HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tomas Norman Dam Selected Research
Tomas Norman Dam Research Topics
Disease
11
Psoriasis (Pustulosis Palmaris et Plantaris)
06/2021 - 02/2006
3
Neoplasms (Cancer)
01/2016 - 10/2013
1
Necrosis
10/2021
1
Skin Neoplasms (Skin Cancer)
10/2013
1
Melanoma (Melanoma, Malignant)
10/2013
1
Skin Diseases (Skin Disease)
10/2013
1
Diabetes Mellitus
01/2012
1
Dyslipidemias (Dyslipidemia)
01/2012
1
Hypertension (High Blood Pressure)
01/2012
1
Urinary Bladder Neoplasms (Bladder Cancer)
02/2010
1
Inflammation (Inflammations)
02/2006
Drug/Important Bio-Agent (IBA)
3
Biological Products
IBA
06/2021 - 01/2012
3
Pharmaceutical Preparations
IBA
01/2021 - 02/2010
2
valrubicin (AD 32)
FDA Link
10/2013 - 02/2010
1
Ustekinumab (CNTO 1275)
FDA Link
10/2021
1
secukinumab
IBA
10/2021
1
Interleukin-12 (IL 12)
IBA
10/2021
1
Biosimilar Pharmaceuticals
IBA
06/2021
1
Adalimumab (Humira)
FDA Link
06/2021
1
apremilast
IBA
12/2019
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
11/2014
1
CUDC 305
IBA
11/2014
1
Anthracyclines
IBA
10/2013
1
Cholesterol
IBA
01/2012
1
Angiotensin Receptor Antagonists
IBA
01/2012
1
Antihypertensive Agents (Antihypertensives)
IBA
01/2012
1
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
01/2012
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
05/2011
1
Solutions
IBA
02/2010
1
Caspases
IBA
02/2010
1
Cytostatic Agents
IBA
02/2010
1
Cytokines
IBA
09/2008
1
interleukin 20 (IL-20)
IBA
09/2008
1
bimosiamose
IBA
02/2006
1
Selectins
IBA
02/2006
Therapy/Procedure
4
Therapeutics
01/2021 - 02/2006
4
Heterologous Transplantation (Xenotransplantation)
11/2014 - 09/2008
2
Aftercare (After-Treatment)
01/2016 - 02/2006
1
Drug Therapy (Chemotherapy)
01/2012